These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 17033754)

  • 21. Surveillance and treatment protocols to detect and treat hepatitis B virus reactivation in hepatitis B surface antigen-negative/antibody to hepatitis B core antigen-positive patients receiving chemotherapy for onco-hematologic malignancies.
    Marignani M; Marzano A
    J Clin Oncol; 2011 Mar; 29(8):e210; author reply e211. PubMed ID: 21220585
    [No Abstract]   [Full Text] [Related]  

  • 22. Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients.
    Pei SN; Chen CH; Lee CM; Wang MC; Ma MC; Hu TH; Kuo CY
    Ann Hematol; 2010 Mar; 89(3):255-62. PubMed ID: 19697028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient.
    Awerkiew S; Däumer M; Reiser M; Wend UC; Pfister H; Kaiser R; Willems WR; Gerlich WH
    J Clin Virol; 2007 Jan; 38(1):83-6. PubMed ID: 17134939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy.
    Hui CK; Cheung WW; Au WY; Lie AK; Zhang HY; Yueng YH; Wong BC; Leung N; Kwong YL; Liang R; Lau GK
    Gut; 2005 Nov; 54(11):1597-603. PubMed ID: 16000641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature.
    Kempinska A; Kwak EJ; Angel JB
    Clin Infect Dis; 2005 Nov; 41(9):1277-82. PubMed ID: 16206102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management.
    Lubel JS; Angus PW
    J Gastroenterol Hepatol; 2010 May; 25(5):864-71. PubMed ID: 20546439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatal liver failure with the emergence of hepatitis B surface antigen variants with multiple stop mutations after discontinuation of lamivudine therapy.
    Zhang JM; Wang XY; Huang YX; Yin YK; Guan S; Xu Y; Roggendorf M; Lu M
    J Med Virol; 2006 Mar; 78(3):324-8. PubMed ID: 16419112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lamivudine prophylaxis for hepatitis B virus infection after lung transplantation.
    Shitrit AB; Kramer MR; Bakal I; Morali G; Ben Ari Z; Shitrit D
    Ann Thorac Surg; 2006 May; 81(5):1851-2. PubMed ID: 16631684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis.
    Coiffier B
    Cancer Invest; 2006; 24(5):548-52. PubMed ID: 16939967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti-HBc negative patient.
    Feeney SA; McCaughey C; Watt AP; Agnaf MR; McDougall N; Wend UC; Gerlich WH; Coyle PV
    J Med Virol; 2013 Apr; 85(4):597-601. PubMed ID: 23359331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of using hepatitis B virus core antibody or surface antigen-positive donors in kidney or pancreas transplantation.
    Akalin E; Ames S; Sehgal V; Murphy B; Bromberg JS
    Clin Transplant; 2005 Jun; 19(3):364-6. PubMed ID: 15877799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatitis B reactivation in an HbsAg-negative/anti-HBc-positive patient with B-cell non-Hodgkin lymphoma receiving chemotherapy with rituximab].
    Muñoz Bertrán E; Pérez Ceballos E; Gómez Espín R; Ortega González I
    Gastroenterol Hepatol; 2010 May; 33(5):377-81. PubMed ID: 20363054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature.
    Zingarelli S; Frassi M; Bazzani C; Scarsi M; Puoti M; Airò P
    J Rheumatol; 2009 Jun; 36(6):1188-94. PubMed ID: 19447932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lamivudine therapy for a hepatitis B surface antigen (HBsAg)-positive leukemia patient receiving myeloablative chemotherapy and autologous stem cell transplantation.
    Uchida N; Gondo H; Himeji D; Kaji Y; Sata M; Niho Y
    Bone Marrow Transplant; 2000 Dec; 26(11):1243-5. PubMed ID: 11149741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience.
    Papadopoulos N; Deutsch M; Manolakopoulos S; Bitsi C; Michalakeas H; Poulakidas H; Tsironi E; Giannouli S; Papatheodoridis GV; Koskinas J; Pectasides D
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):56-60. PubMed ID: 27669175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor response to 18-month lamivudine monotherapy in chronic hepatitis B patients with IgM anti-HBc and acute exacerbation.
    Chen JJ; Lin CY; Sheu MJ; Kuo HT; Sun CS; Tang LY; Wang SL; Tsai SL
    Aliment Pharmacol Ther; 2006 Jan; 23(1):85-90. PubMed ID: 16393284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatitis B virus reactivation after allogeneic bone marrow transplantation in a patient previously cured of hepatitis B].
    Romand F; Michallet M; Pichoud C; Trépo C; Zoulim F
    Gastroenterol Clin Biol; 1999; 23(6-7):770-4. PubMed ID: 10470533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Permanent loss of anti-HBc after reactivation of hepatitis B virus infection in an anti-HBs and anti-HBc-positive patient after allogeneic stem cell transplantation.
    Gärtner BC; Jung W; Welsch C; Fischinger J; Schubert J; Zeuzem S; Mueller-Lantzsch N; Wend UC; Gerlich WH
    J Clin Virol; 2007 Feb; 38(2):146-8. PubMed ID: 17182277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus reactivation and alemtuzumab therapy.
    Iannitto E; Minardi V; Calvaruso G; Mulè A; Ammatuna E; Di Trapani R; Ferraro D; Abbadessa V; Craxí A; Di Stefano R
    Eur J Haematol; 2005 Mar; 74(3):254-8. PubMed ID: 15693796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.